Concepedia

James W. Mier

JW

Statistics

Publications

79

Citations

10.3K

H-Index

42

Active since

1980

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Dana-Farber Cancer Institute

Tufts Medical Center

Tufts University

James W. Mier is an author at Beth Israel Deaconess Medical Center specializing in medicine, oncology, and pharmacology.

Publications per year

1980–2020

79

Publications

79

Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion

Arnold H. Zea, Paulo C. Rodrı́guez, Michael B. Atkins et al. · Cancer Research · 2005 · 833 citations

Medicine, Immunology, Oncology +17

Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma

David F. McDermott, Meredith M. Regan, Joseph I. Clark et al. · Journal of Clinical Oncology · 2004 · 819 citations

Medicine, Oncology, Pharmacotherapy +15

Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma

Jeffrey J. Wallin, Johanna C. Bendell, Roel Funke et al. · Nature Communications · 2016 · 713 citations · Full text

Medicine, Oncology, Pharmacology +17

Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis

Arthur Kaser, Gerald Brandacher, Wolfgang Steurer et al. · Blood · 2001 · 653 citations · Full text

Medicine, Hematology, Immunology +14

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

Vicky Makker, Matthew H. Taylor, Carol Aghajanian et al. · Journal of Clinical Oncology · 2020 · 522 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

1–5 of 79